Navigation Links
GenWay Biotech Appoints New Vice President of Custom/OEM
Date:5/1/2012

SAN DIEGO, May 1, 2012 /PRNewswire-iReach/ -- GenWay Biotech today announced the appointment of Mark Fitchmun as the company's new Vice President of GenWay Custom/OEM. This position was created as part of GenWay Biotech's efforts to focus on growth of the individual divisions including GenWay Custom/OEM, GenWay Catalog, and FirstMark Diagnostics. Since 1998, GenWay Biotech has provided the diagnostic and research communities with thousands specialty reagents and assays with unmatched quality workmanship at affordable prices. The company is recognized as a trusted out-sourcing partner throughout the world.

"GenWay leads the industry in product quality and customer satisfaction. We are truly proud of our reputation, and grateful for our customer's trust and support. Our customer's success, and contribution to our shareholders return on investment are the driving factors behind GenWay, and we are leveraging this success for our growth plans," stated Thomas Silberg, President and CEO of GenWay Biotech. "Mark's dedication to customer satisfaction, and his extensive experience in the biopharmaceutical industry developing and implementing robust manufacturing processes and assays, will be integral to GenWay Biotech's growth plans. We look forward to having him apply those same skills at GenWay."

As Vice President of GenWay Custom/OEM division, Fitchmun's primary role will be to lead the strategic direction for growth and day-to-day activities for the division. Fitchmun's 25 years of leadership and technical experience in the biopharmaceutical industry has ranged from small entrepreneurial biotech startups, to large established equipment and pharmaceutical companies. Since 1992, Fitchmun served as Principal for Somateck, Inc., where he provided development, manufacturing, and project management support to companies creating next generation biopharmaceuticals, diagnostics, research reagents, and k
'/>"/>

SOURCE GenWay Biotech
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
2. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
3. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
4. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
5. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
6. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
7. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
8. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
9. Hawaii Biotech Receives Allowance to Perform West Nile Vaccine Clinical Trials
10. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
11. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... DUBLIN , May 27, 2015 /PRNewswire/ ... ) has announced the addition of the  ... Testing Market"  report to their offering.  ... ,This comprehensive five-country report contains 500 pages, ... current suppliers and potential market entrants identify ...
(Date:5/27/2015)... May 27, 2015 OpportunityAnalyzer: Sepsis - Opportunity ... patients suffer from a series of diverse complications arising ... the blood or tissues, which cause a rapidly progressing ... mortality rates near 50% depending on disease severity. The ... systems of the global marketplace, which for the purposes ...
(Date:5/27/2015)... PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market ... is an autoimmune disease that permanently destroys beta cells of ... longer produce insulin. Over the last 90 years, insulin therapy ... can be offered to a patient who is newly diagnosed ... of action - long-acting as well as short or rapid-acting ...
Breaking Medicine Technology:European Hemostasis Diagnostic Testing Market Strategies 2015 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 3OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 4PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4
... CITY, Calif., July 7 Relievant Medsystems, Inc., developer ... back pain, reported today that it has completed a ... led by Morgenthaler Ventures with existing investors Canaan Partners ... participating. The company also announced that Morgenthaler partner ...
... Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ... study of Lantus(R) (insulin glargine [rDNA] injection) versus NPH insulin ... published on-line in Diabetologia ... in the two treatment groups. This is the longest controlled ...
Cached Medicine Technology:Relievant Medsystems Announces Completion of $20 Million Financing 2Relievant Medsystems Announces Completion of $20 Million Financing 35-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH 25-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH 35-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH 45-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH 5
(Date:5/28/2015)... May 28, 2015 Although many people ... stuck with their slow metabolism for life, never being ... is not true. There are methods to jump start ... advertisements for low-carbohydrate, low-fat and no-fat foods, cleverly worded ... healthy, many times the foods contain hidden ingredients and ...
(Date:5/28/2015)... Texas (PRWEB) May 28, 2015 ... an updated version of his patient education website ... website redesign allows patients to readily access current ... erectile dysfunction treatment, male urinary incontinence, prostate cancer ... goal of this website is to educate patients ...
(Date:5/28/2015)... 28, 2015 SpendWell Health, an e-commerce ... has been named a “Cool Vendor” by Gartner in ... in Healthcare Payers, 2015 by Jeff Cribbs, Constance ... highlights innovative vendors, products and services in health care ... the health care payer market. , SpendWell’s solution ...
(Date:5/28/2015)... Sunshine Coast Health Center, one of ... at http://www.sunshinecoasthealthcentre.ca , is proud to announce ... the Toronto, Ontario, community. The company has a ... its online location information for Toronto residents. , ... we realize that addiction impacts family and friends," ...
(Date:5/28/2015)... The Cancer Solution: Taking Charge of ... researched and heartfelt book the Booksandauthor reviewer ever ... for writing what should be one of the most ... there is power in action and this book has both. ... to talk about and unfortunately many persons know little about ...
Breaking Medicine News(10 mins):Health News:As Part of their Comprehensive Weight Loss Program, Diet Doc Now Teaches Patients how to Identify Hidden Carbohydrates for Safe, Fast and Long Term Weight Loss Success 2Health News:As Part of their Comprehensive Weight Loss Program, Diet Doc Now Teaches Patients how to Identify Hidden Carbohydrates for Safe, Fast and Long Term Weight Loss Success 3Health News:As Part of their Comprehensive Weight Loss Program, Diet Doc Now Teaches Patients how to Identify Hidden Carbohydrates for Safe, Fast and Long Term Weight Loss Success 4Health News:Mark Allen MD, Dallas Urologist, Launches Updated Patient Education Website With a Focus on Prostate Cancer and Erectile Dysfunction Treatment 2Health News:SpendWell Named a “Cool Vendor” by Gartner 2Health News:SpendWell Named a “Cool Vendor” by Gartner 3Health News:SpendWell Named a “Cool Vendor” by Gartner 4Health News:Toronto Alcohol Treatment and Drug Rehab Local Information Page Updated, Announces Sunshine Coast Health Center 2Health News:Toronto Alcohol Treatment and Drug Rehab Local Information Page Updated, Announces Sunshine Coast Health Center 3Health News:Booksandauthor Cites The Cancer Solution as One of the Most Important Books to Read 2
... in teen, adult females, but not in men, study ... is associated with delayed childbearing in women, according to ... of alcohol dependence and their age when they had ... from two groups of Australian twins born between 1893-1964 ...
... Co., Inc. (OTC Bulletin Board: TYNP, TYNPE), a ... based in,Chengdu, China, today announced that the Company,s ... TYNPE due to the electronic eligibility,system error., ... Company expects the,stock symbol to trade under the ...
... Edward,G. Rendell today said Pennsylvania,s agricultural industry is ... system, underscoring the need,to secure the state,s energy ... Nearly 900 guests gathered to hear the ... at Ag Progress Days, Pennsylvania,s,largest outdoor agricultural exposition., ...
... (MGH) investigators have found that infusions of a particular ... from autoimmune attack in a mouse model. In ... , the team from the MGH Center for Engineering ... to control several immune system activities, allowed the regeneration ...
... Four Girls to My Beauty Camp ... this ... with the popular teenage Web site ELLEgirl.com to send four contest,winners later ... the new school year approaching, the goal of the camp is,to empower ...
... FALLS CHURCH, Va., Aug. 20 Scientists,physicians, ... Food,and Drug Administration,s (FDA) announcement that bisphenol A ... products including can,linings and baby bottles - is ... obesity, developmental problems, risk for heart,attack, and breast ...
Cached Medicine News:Health News:Women's Alcohol Use Tied to Delayed Childbearing 2Health News:Tianyin Pharmaceutical Co., Inc. Announces Trading Symbol Error and Correction 2Health News:Pennsylvania Governor Rendell Highlights Renewable Energy, Health Care Reform at Ag Progress Days 2Health News:Bone marrow stem cells may help control inflammatory bowel disease 2Health News:Bone marrow stem cells may help control inflammatory bowel disease 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 2Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 3Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 4Health News:Special Summer Camp Helps Girls Recognize Inner and Outer Beauty 5Health News:FDA Decision on BPA Outrages Health Advocates 2Health News:FDA Decision on BPA Outrages Health Advocates 3
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
... ELISA products make us a leader in ... faster integration into the busy laboratory, our ... and run-to-run consistency. Our Infectious Disease ELISA ... wide range of serological assays including ToRCH, ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... DIFF CHEK-30 is a rapid ELISA ... 100% negative predictive value and 99% sensitivity. ... and cost-effectively screen out C. difficile negatives ... of samples - before culturing for the ...
Medicine Products: